Oppenheimer & CO Inc Black Rock Health Sciences Trust Transaction History
Oppenheimer & CO Inc
- $6.52 Billion
- Q4 2024
A detailed history of Oppenheimer & CO Inc transactions in Black Rock Health Sciences Trust stock. As of the latest transaction made, Oppenheimer & CO Inc holds 5,809 shares of BME stock, worth $235,206. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,809
Previous 5,892
1.41%
Holding current value
$235,206
Previous $247,000
10.93%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BME
# of Institutions
76Shares Held
3.2MCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY386KShares$15.6 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA339KShares$13.7 Million0.0% of portfolio
-
Nova R Wealth, Inc.320KShares$13 Million6.39% of portfolio
-
Invesco Ltd. Atlanta, GA223KShares$9.04 Million0.0% of portfolio
-
1607 Capital Partners, LLC Richmond, VA176KShares$7.13 Million0.54% of portfolio
About BlackRock Health Sciences Trust
- Ticker BME
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in r...